NIH-funded research R01 grant

International collaboration mapping genes and brain scans in Tourette syndrome

Official title: Tourette Syndrome genetics and neuroimaging international collaborative study

Funded at Purdue University · NIH-11250036 · Data updated 2026-11-12

This project brings together MRI brain scans and genetic data from people with Tourette syndrome and related conditions to spot biological patterns linked to tics and co-occurring symptoms.

More Tourette Syndrome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPurdue University
NIH-funded
Lab location1 site (West Lafayette, United States)
Project startMarch 4, 2022
Project endDecember 31, 2026
Funding year2026
Award (this year)$488,047
NIH project number5R01MH126213-05
Project IDNIH-11250036 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with Tourette syndrome—especially children and adolescents—and those with common co-occurring diagnoses such as ADHD, OCD, ASD, anxiety, or depression, as well as healthy volunteers for comparison.

Less likely to help

People looking for immediate new treatments or those without Tourette syndrome or related neuropsychiatric conditions are unlikely to receive direct clinical benefit from participation.

What this research studies

You would join a large international effort that combines brain MRI scans and genetic data from people with Tourette syndrome and from those with common co-occurring conditions like ADHD, OCD, autism, anxiety, and depression. Participants may provide a DNA sample, medical records, and/or undergo a standardized MRI scan at a participating site or contribute existing data. Researchers use shared processing pipelines and pooled data from many centers to find consistent brain and genetic features tied to tics and comorbidity. The goal is to explain why some people with Tourette's develop additional psychiatric conditions and to lay the groundwork for better-targeted care in the future.

Why it matters

Potential benefit: If successful, the work could identify brain and genetic markers that improve diagnosis and help guide development of more targeted treatments for Tourette syndrome and related conditions.

How similar studies have gone: Large international consortia like ENIGMA have successfully pooled MRI and genetic data to find brain signatures in other psychiatric disorders, and prior Tourette genetics work has shown some risk signals, but this broad integrated approach is relatively new for TS.

Where this research is happening

  • Purdue University
    West Lafayette, United States
    Active

Researchers

  • Principal investigator: Paschou, Peristera — Purdue University
  • Study coordinator: Paschou, Peristera

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.